A new experimental obesity drug from Eli Lilly helped patients lose an average of about 85 pounds in a late-stage clinical ...

Common preservatives used in many store-bought foods were linked to a 29% greater risk of elevated blood pressure and a 16% ...

Glucose tracking is moving beyond diabetes care as CGMs, AI platforms, and wearable sensors reshape personalized health data ...

Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to ...

A suite of new studies suggest drugs such as Ozempic and Zepbound might slow tumor progression and improve survival, but more ...

Novant Health Wellness & Education Thomasville will offer a free educational seminar to learn more about diabetes management ...

A web of mail-order pharmacies, wholesalers and patient services groups connected to the self-styled largest Pentecostal ...

Participants on weekly injections of 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks, and 45.3% of participants achieved ≥ 30% weight loss.

The 22nd annual Andy Hogan Memorial Golf Outing is scheduled for June 6 to benefit the Edgar County Diabetes Association, ...

A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one ...

These dietitian-recommended choices are tasty, nutritious, affordable and convenient—plus they stay fresh in the pantry.

Hims & Hers Health said on Thursday it is now offering Canadians with type 2 diabetes a ​generic version of semaglutide, the active ingredient in ‌Novo Nordisk's blockbuster drug Ozempic, through its ...